<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T07:21:37Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:10230/46448" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:10230/46448</identifier><datestamp>2025-12-23T20:53:32Z</datestamp><setSpec>com_2072_6</setSpec><setSpec>col_2072_452954</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Business plan of Nanotarg: a technological platform aiming to treat pancreatic cancer</dc:title>
   <dc:creator>Garriga Ferrer, Martina</dc:creator>
   <dc:subject>Entrepreneurship</dc:subject>
   <dc:subject>Spin-off</dc:subject>
   <dc:subject>Nanotechnological platform</dc:subject>
   <dc:subject>Specific targeting</dc:subject>
   <dc:subject>Pancreatic cancer</dc:subject>
   <dcterms:abstract>Treball de fi de grau en Biomèdica</dcterms:abstract>
   <dcterms:abstract>Tutor: Pilar Rivera Gil</dcterms:abstract>
   <dcterms:abstract>Pharmaceutical industry is one of the most relevant activities and plays a major role in&#xd;
economics and the provision of global health. It is known that the processes of developing&#xd;
new compounds and its entry to the market are very complex and require specific&#xd;
guidelines that can only be provided by business and regulatory analytics. Although the&#xd;
key players in such industry are big companies, drug development is becoming a&#xd;
cooperative effort encouraging technology transfer since many compounds have their&#xd;
discovery origins in academia and small innovative companies, such as spin-offs.&#xd;
In this thesis, a business plan of the nanotechnological platform Nanotarg is presented.&#xd;
This technology, whose origin arises from academic research in Universitat Pompeu&#xd;
Fabra, enables specific targeting to tumoral tissue in the pancreas and can potentially&#xd;
release the therapeutic gold standard to increase the survival rate of pancreatic cancer&#xd;
patients.&#xd;
The goal of this project is to provide clear strategy lines for those researchers aiming to&#xd;
start the path of entrepreneurship. These business strategies derive from the exhaustive&#xd;
analysis of different features that affect pharmaceutical business development, among&#xd;
others, opportunity and market analysis are performed, as well as the SWOT and PESTEL&#xd;
analysis and financial projections to ensure profits and revenues.</dcterms:abstract>
   <dcterms:issued>2021-02-11T12:44:48Z</dcterms:issued>
   <dcterms:issued>2021-02-11T12:44:48Z</dcterms:issued>
   <dcterms:issued>2020-07</dcterms:issued>
   <dc:type>info:eu-repo/semantics/bachelorThesis</dc:type>
   <dc:rights>Atribución-NoComercial-SinDerivadas 3.0 España</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/3.0/es/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>